|
Market Closed -
NYSE
16:00:02 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 80.41 USD | -0.30% |
|
-4.05% | -20.25% |
| 10-01 | BNP Paribas Adjusts Price Target on Clorox to $89 From $96, Maintains Neutral Rating | MT |
| 10-01 | TD Cowen Adjusts Clorox Price Target to $85 From $90, Maintains Hold Rating | MT |
Company Valuation: The Clorox Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 17,352 | 19,661 | 16,948 | 14,799 | 11,541 | 9,724 | - | - |
| Change | - | 13.31% | -13.8% | -12.68% | -22.02% | -15.74% | - | - |
| Enterprise Value (EV) 1 | 19,880 | 21,821 | 19,231 | 17,120 | 16,465 | 14,607 | 14,497 | 14,546 |
| Change | - | 9.77% | -11.87% | -10.98% | -3.83% | -11.28% | -0.75% | 0.34% |
| P/E | 37.8x | 133x | 60.7x | 18.4x | 19.8x | 14.1x | 12.7x | 12x |
| PBR | 31.2x | 89.5x | 51.7x | 45.9x | 128x | 41.8x | 32.3x | 23.7x |
| PEG | - | -2x | 0.7x | 0x | -0.8x | 0.8x | 1.1x | 2.1x |
| Capitalization / Revenue | 2.44x | 2.66x | 2.39x | 2.08x | 1.72x | 1.27x | 1.24x | 1.21x |
| EV / Revenue | 2.8x | 2.95x | 2.71x | 2.41x | 2.45x | 1.91x | 1.86x | 1.81x |
| EV / EBITDA | 20.4x | 18.9x | 15x | 11.2x | 12.9x | 10.5x | 9.8x | 9.49x |
| EV / EBIT | 26.5x | 23.8x | 18.4x | 13x | 16x | 12.9x | 11.9x | 11.5x |
| EV / FCF | 37.2x | 23.5x | 39.8x | 22.5x | 18.7x | 16.6x | 17x | 16x |
| FCF Yield | 2.69% | 4.26% | 2.51% | 4.45% | 5.35% | 6.03% | 5.88% | 6.25% |
| Dividend per Share 2 | 4.66 | 4.72 | 4.8 | 4.88 | 4.96 | 5.121 | 5.312 | 5.558 |
| Rate of return | 3.31% | 2.97% | 3.52% | 4.06% | 5.2% | 6.37% | 6.61% | 6.91% |
| EPS 2 | 3.73 | 1.2 | 2.25 | 6.52 | 4.81 | 5.683 | 6.32 | 6.681 |
| Distribution rate | 125% | 393% | 213% | 74.8% | 103% | 90.1% | 84.1% | 83.2% |
| Net sales 1 | 7,107 | 7,389 | 7,093 | 7,104 | 6,720 | 7,630 | 7,812 | 8,038 |
| EBITDA 1 | 974 | 1,153 | 1,280 | 1,535 | 1,277 | 1,391 | 1,479 | 1,533 |
| EBIT 1 | 750 | 917 | 1,045 | 1,316 | 1,030 | 1,129 | 1,213 | 1,270 |
| Net income 1 | 462 | 149 | 280 | 810 | 587 | 692.7 | 757.2 | 789 |
| Net Debt 1 | 2,528 | 2,160 | 2,283 | 2,321 | 4,924 | 4,883 | 4,773 | 4,822 |
| Reference price 2 | 140.98 | 159.04 | 136.47 | 120.07 | 95.44 | 80.41 | 80.41 | 80.41 |
| Nbr of stocks (in thousands) | 123,080 | 123,624 | 124,188 | 123,253 | 120,921 | 120,931 | - | - |
| Announcement Date | 8/3/22 | 8/2/23 | 8/1/24 | 7/31/25 | 8/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.15x | 1.91x | 10.5x | 6.37% | 9.72B | ||
| 17.03x | 3.05x | 11x | 4.4% | 41.38B | ||
| 25.47x | 3.87x | 16.55x | 1.31% | 22.37B | ||
| 13.78x | 1.6x | 9.11x | 4.1% | 4.7B | ||
| 14.12x | 1.63x | 9.7x | 10.44% | 3.35B | ||
| 18.71x | 0.9x | 6.85x | 1.97% | 3.03B | ||
| 32.8x | 4.04x | 21.99x | - | 2.72B | ||
| 25.22x | 1.05x | 16.85x | 4.17% | 1.68B | ||
| Average | 20.16x | 2.26x | 12.82x | 4.68% | 11.12B | |
| Weighted average by Cap. | 19.25x | 2.92x | 12.50x | 3.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLX Stock
- Valuation The Clorox Company
Select your edition
All financial news and data tailored to specific country editions
















